Thylacine Bio engages in developing a peptide platform for pandemic preparedness.
Thylacine Bio has raised $476K in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Thylacine Bio is headquartered in Miami Beach, United States.
Thylacine Bio engages in developing a peptide platform for pandemic preparedness.
Thylacine Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thylacine Bio — Funding & Investors." VCBacked, January 19, 2023, https://www.vcbacked.co/company/thylacine-bio. Accessed September 30, 2026.
VCBacked. (2023). Thylacine Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/thylacine-bio
{{cite web |title=Thylacine Bio — Funding & Investors |url=https://www.vcbacked.co/company/thylacine-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated